Liver transplantation in children

Area of Science:

• Hepatology
• Pediatric Surgery
• Immunology

Background:

• Liver transplantation (LT) is a standard treatment for pediatric end-stage liver disease, achieving excellent survival rates.
• Improvements in surgical techniques, anti-rejection therapies, and donor pool expansion (e.g., split, living-related, hepatocyte transplantation) have contributed to successful outcomes.
• Despite advancements, transplanted children face significant short-term and long-term complications, often linked to immunosuppressive drug toxicity.

Purpose of the Study:

• To review the current status and challenges of pediatric liver transplantation.
• To highlight the need for research focused on mitigating complications associated with immunosuppression.

Main Methods:

• Review of current literature and clinical practices in pediatric liver transplantation.
• Analysis of survival rates, common complications, and the impact of immunosuppressive therapy.

Main Results:

• Pediatric LT demonstrates high 1- and 5-year survival rates.
• Complications include primary non-function, vascular/biliary issues, infection, rejection, and long-term renal impairment, de novo autoimmunity, and malignancy.
• Many complications are attributed to the toxicity of anti-rejection drugs.

Conclusions:

• While pediatric liver transplantation is highly successful, managing immunosuppression remains a critical challenge.
• Future research must prioritize the induction of immune tolerance to reduce long-term drug toxicity and improve patient quality of life.